Cystaran
NIH Encourages Americans to Make Vision a Priority »
"In May, Healthy Vision Month, the National Eye Institute (NEI) calls on Americans to make their vision a priority by taking the necessary steps to protect vision, prevent vision loss, and make the most of the vision they may have remaining.
"...Read the NIH Encourages Americans to Make Vision a Priority article »
Cystaran
CYSTARAN
(cysteamine) Ophthalmic Solution
DRUG DESCRIPTION
CYSTARAN is a sterile ophthalmic solution containing 6.5 mg/mL of cysteamine hydrochloride, equivalent to 4.4 mg/mL of cysteamine (0.44%) as the active ingredient. Cysteamine is a cystine-depleting agent which lowers the cystine content of cells in patients with cystinosis.
 |
Molecular Formula: C2H7NS HCl
Molecular Weight: 113.61
Each milliliter of CYSTARAN contains: Active: cysteamine 4.4 mg (equivalent to cysteamine hydrochloride 6.5 mg); Preservative: benzalkonium chloride 0.1 mg; Inactive Ingredients: sodium chloride, hydrochloric acid and/or sodium hydroxide (to adjust pH to 4.1-4.5), and purified water.
Last reviewed on RxList: 10/11/2012
This monograph has been modified to include the generic and brand name in many instances.
Additional Cystaran Information
Report Problems to the Food and Drug Administration
You are encouraged to report negative side effects of prescription drugs to the FDA. Visit the FDA MedWatch website or call 1-800-FDA-1088.
WebMD Daily
Get breaking medical news.
Updated & New
